(Q46970662)

27 December 2017

title

Effects of fluvastatin slow-release (XL 80 mg) versus simvastatin (20 mg) on the lipid triad in patients with type 2 diabetes (English)

1 reference

27 December 2017

1 reference

1 reference

Maurizio Bevilacqua

1

1 reference

27 December 2017

Velella Righini

2

1 reference

27 December 2017

Massimo Barrella

3

1 reference

27 December 2017

Tarcisio Vago

4

1 reference

27 December 2017

Enrica Chebat

5

1 reference

27 December 2017

Ligia J Dominguez

6

1 reference

27 December 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

27 December 2017

published in

Advances in Therapy

1 reference

27 December 2017

volume

22

1 reference

27 December 2017

issue

6

1 reference

27 December 2017

page(s)

527-542

1 reference

27 December 2017

https://scigraph.springernature.com/pub.10.1007/bf02849947

exact match

0 references

cites work

United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1007%2FBF02849947

Atherogenic role of elevated CE transfer from HDL to VLDL(1) and dense LDL in type 2 diabetes : impact of the degree of triglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02849947

Assessment of LDL Particle Size by Triglyceride/HDL-Cholesterol Ratio in Non-diabetic,Healthy Subjects without Prominent Hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02849947

Effects of fluvastatin in type 2 diabetic patients with hyperlipidemia: reduction in cholesterol oxidation products and VCAM-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02849947

Fluvastatin lowers atherogenic dense low-density lipoproteins in postmenopausal women with the atherogenic lipoprotein phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02849947

Common hepatic lipase gene promoter variant determines clinical response to intensive lipid-lowering treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02849947

21 January 2018

Identifiers

DOI

10.1007/BF02849947

1 reference

27 December 2017

1 reference

27 December 2017